In this study, we demonstrated that the anticancer activity of Wi-A and CAPE is mediated by downregulation of mortalin and PARP1, yielding upregulation of tumor suppressor p53 and DNA-damage signaling leading to growth arrest/apoptosis in cancer cells. Here, TP53 is linked to cancer.